3902 — Medical Data Vision Co Cashflow Statement
0.000.00%
Annual cashflow statement for Medical Data Vision Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,592 | 1,427 | 1,568 | -727 | 66 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -47.5 | 300 | 234 | 736 | 301 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -597 | -966 | -287 | -1,015 | 306 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,083 | 911 | 1,616 | -878 | 782 |
| Capital Expenditures | -24 | -53.2 | -30.2 | -154 | -62.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.89 | -816 | -408 | -438 | -34.6 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26.9 | -869 | -438 | -593 | -96.9 |
| Financing Cash Flow Items | -0.001 | 110 | — | — | -0.101 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -1,031 | -979 | -225 | -400 | -319 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.1 | -937 | 953 | -1,871 | 366 |